AFT Pharmaceuticals Limited (ASX:AFP) revealed its annual results and disclosed that revenue for the year to 31 March 2020 increased 24% to NZ$105.6 million from NZ$85.1 million in the prior financial year, with revenue increasing strongly in Australia (up by 22%), New Zealand (up by 12%) and Southeast Asia (up by 130%).
Net profit after tax increased to NZ$12.7 million from a loss of NZ$2.4 million in the previous corresponding period.
The Company highlighted that it has observed strong increases in sales for pain killers, cold & flu medicines and vitamin C products.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.